The activity of β-hexosaminidase (uHex) and y-glutamyltransferase (uGGT) in urine as non-invasive markers of chronic alcohol abuse: II. Opiate-dependent subjects receiving methadone substitution

World Journal of Biological Psychiatry

Volumn 3, Issue 1, 2002, Pages 44-49

  Taracha, Ewa ^a   Habrat, Boguslaw ^a   Baran, Helena ^a   Chmielewska, Karlna ^a   Walkowlak, Jerzy ^a   Szukalski, Bogdan ^a  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

CUT; markers of alcohol abuse; methadone maintenance programme; urine hexosaminidase; urine glutamyltransferase

Indexed keywords

BETA N ACETYLHEXOSAMINIDASE; GAMMA GLUTAMYLTRANSFERASE; METHADONE; NARCOTIC AGENT;

ADULT; ALCOHOLISM; ARTICLE; CHRONIC DISEASE; ENZYMOLOGY; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; OPIATE ADDICTION; ROC CURVE; URINE;

ADULT; ALCOHOLISM; BETA-N-ACETYLHEXOSAMINIDASE; CHRONIC DISEASE; FOLLOW-UP STUDIES; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; MALE; METHADONE; MIDDLE AGED; NARCOTICS; OPIOID-RELATED DISORDERS; ROC CURVE;

EID: 0036047361     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622970209150600     Document Type: Article

References (40)

1. Aithal GP, Thornes H, Dwarakanath AD, Tanner AR (1998) Measurement of carbohydrate-deficient transferrin (CUT) in general medical clinic: is this test useful in assessing alcohol consumption? Alcohol Alcohol 33:304-309.
2. Anton RF (2000) Carbohydrate deficient transferrin (CDT) as a marker for heavy alcohol use: What have we learned; Where do we go from here. Alcohol Clin Exp Res 24(Suppl 5):172A.
3. Anton RF, Litten RZ, Allen JP (1995) Biological assessment of alcohol consumption. Assessing alcohol problems a guide for clinicians and researchers. In: Allen JP, Columbus M (eds) Treatment Handbook Series 4. NIAAA, Bethesda, pp 31-39.
4. Babor TF, de la Fuente JR, Saunders J, Grant K (1989) AUDIT. The Alcohol USE Disorders Identification TEST. Guidelines for Use in Primary Health Care. WHO, Geneva.
5. Bell H, Tallaksen CME, Try K, Haug E (1994) Carbohydrate-deficient transferrin and other markers of high alcohol consumption: a study of 502 patients admitted consecutively to a medical department. Alcohol Clin Exp Res 18:1103-1108.
6. Bisson Jl, Milford-Ward A (1994) A comparison of carbohydrate deficient transferrin with other markers of alcohol misuse in male soldiers under the age of thirty. Alcohol Alcohol 29:315-321.
7. Chatham LR, Rowan-Szal GA, Joe GW, Brown BS, Simpson DD (1995) Heavy drinking in a population of methadone-maintained clients. J Stud Alcohol 56:417-422.
8. Chatham LR, Rowan-Szal GA Joe GW, Simpson DD (1996) Heavy drinking, alcohol-dependent vs. nondependent methadone maintenence clients: a follow-up study. Addictive Behaviors 22:69-80.
9. El-Bassel N, Schilling RF, Tumbull JE, Kuo-Hsien S (1993) Correlates of alcohol use among methadone patients. Alcohol Clin Exp Res 17:681-686.
10. Elomaa V-V, Löyttyniemi E, Kärkkäinen P, Salaspuro M, Laitinen K (1996) Biological markers of alcohol consumption and effect of calcitonin in nonalcoholic men: a prospective, double-blind study. Alcohol Clin Exp Res 20:830-835.
11. Flynn FV (1990) Assessment of renal function: Selected developments. Clin Biochem 23:49-54.
12. Gaedeke J, Fels ML, Bokemeyer C, Mengs U, Stolte H, Lentzen H (1996) Cisplatin nephrotoxity and protection by silibinin. Nephrol Dial Transplant 11:55-62.
13. Grzybowski M, Younger JG (1997) Statistical methodology: III. Receiver Operating Characteristic (ROC) curves. Acad Emerg Med 4:818-826.
14. Habrat B, Czartoryska B, Górska D, Poźniak M, Wehr H (1995) Próba wykorzystania β-heksozoaminidazy jako markera nadużywania alkoholu w leczeniu uzależnienia. Doniesienie wstȩpne. Postȩpy Psychiatrii i Neurologii 4:181-188.
15. Heinemann A, Sterneck M, Kuhlencordt R, Rogiers X, Schulz KH, Queen B, Wischhusen F, Puschel K (1998) Carbohydrate-deficient transferrin: diagnostic efficiency among patients with end-stage liver disease before and after liver transplantation. Alcohol Clin Exp Res 22:1806-1812.
16. Hong CY, Cia KS (1998) Markers of diabetic nephropathy. J Diabet Complications 12:43-60.
17. Huseby N-E, Nilssen O, Erfurth A, Wetterling T, Kanitz RD (1997) Carbohydrate-deficient transferrin and alcohol dependency: variation in response to alcohol intake among different groups of patients. Alcohol Clin Exp Res 21:201-205.
18. Idasiak-Piechocka I, Krzymáski M (1996) The role of tubulointerstitial changes in progression of chronic glomerulonephritis (CN) Przegl Lek 53:443-453.
19. Kärkkäinen P, Salaspuro M (1991) b-hexosaminidase in detection of alcoholism and heavy drinking. Alcohol Alcohol 26(Suppl 1):459-464.
20. Kärkkäinen P, Jokelainen K, Roine R, Suokas A, Salaspuro M (1990) The effects of moderate drinking and abstinence on serum and urinary β-hexosaminidase levels. Drug Alcohol Dependence 25:35-38.
21. Lesch OM, Walter H, Antal J, Heggli DE, Kovacz A, Leitner A, Neumeister A, Stumpf I, Sunderhagen E, Kasper S (1996a) Carbohydrate-deficient tranferrin as a marker of alcohol intake: A study with healthy subjects. Alcohol Alcohol 31:265-271.
22. Lesch OM, Walter H, Freitag H, Heggli DE, Leitner A, Mader R, Neumeister A, Passweg V, Pusch H, Semler B, Sunderhagen E, Kasper S (1996b) Carbohydrate-deficient tranferrin as screeening marker for drinking in a general hospital population. Alcohol Alcohol 31:249-256.
23. Martines D, Morris AI, Gilmore IT, Ansari MA, Patel A, Quayle JA, Billington D (1989) Urinary enzyme output during detoxification of chronic alcoholic patients. Alcohol Alcohol 24:113-120.
24. Meerkerk C-J, Njoo KH, Bongers IMB, Trienkens P, van Oers JAM (1998) The specificity of the CDT assay in general practice: the influence of common chronic diseases and medication on the serum CDT concentration. Alcohol Clin Exp Res 22:908-913.
25. Meregalli M, Giacomini V, Lino S, Marchetti L, DeFeo T, Cappellini MD, Fiorelli C (1995) Carbohydrate-deficient transferrin in alcohol and nonalcohol abusers with liver disease. Alcohol Clin Exp Res 19:1525-1527.
26. Mikkelsen IM, Kanitz RD, Nillsen O Huseby NE (1998) Carbohydrate- deficient transferrin: marker of actual alcohol consumption or chronic alcohol misuse? Alcohol Alcohol 33:646-650.
27. Rebel W, Bertsch T, Bode G, Bleuel H (1992) Enzymuria as an indicator of renal pathomorphology. In: Jung K, Mattenheimer H, Burchardt U (eds) Urinary Enzymes in Clinical and Experimental Medicine. Springer-Verlag, Berlin, Heidelberg, pp 43-66.
28. Reynaud M, Hourcade F, Planche F, Albuisson E, Meunier MN, Planche R (1998) Usefulness of carbohydrate deficient transferrin in alcoholic patients with normal g-glutamyltranspeptidase. Alcohol Clin Exp Res 22:615-618
29. Rosman AS (1992) Utility and evaluation of biochemical markers of alcohol consumption. J Substance Abuse 4:277-297.
30. Rubio M, Caballeria J, Deulofeu R, Caballeria L, Gassó M., Parés A, Vilella A, Giménez A, Ballesta A, Rodés J (1997) Carbohydratedeficient transferrin as a marker of alcohol consumption in male patients with liver disease. Alcohol Clin Exp Res 21:923-927.
31. Salaspuro M (1999) Carbohydrate-deficient transferrin as compared to other markers of alcoholism: A systematic review. Alcohol 19:261-271.
32. Sillanauke P, Aalto M, Seppa K (1998) Carbohydrate-deficient transferrin and conventional markers as indicators for brief intervention among heavy drinkers in primary health care. Alcohol Clin Exo Res 22:892-896.
33. Stauber RE, Stepan V, Trauner M, Wilders-Trusching M, Leb C, Krejs GJ (1995) Evaluation of carbohydrate-deficient transferrin for detection of alcohol abuse in patients with liver dysfunction. Alcohol Alcohol 30:171-176.
34. Stengel B, Watier L, Chouquet C, Cénée S, Philippon C, Hémon D (1999) Influence of renal biomarker variability on the design and interpretation of occupational or environmental studies. Toxicol Letters 106:69-77.
35. Stibler H (1991) Carbohydrate-deficient transferrin in serum: a new marker of potentially harmful alcohol consumption reviewed. Clin Chem 37:2029-2037.
36. Taracha E, Habrat B, Baran-Furga H, Chmielewska K, Woźniak P, Szukalski B (1999a) Zastosowanie oznaczania aktywności β-heksozoaminidazy w moczu i markerów alkoholizmu w surowicy do identyfikacji osób nadużywaja̧cych alkoholu wśród uzaleznionych od opiatów uczestnicza̧cych w programie substytucyjnego leczenia metadonem. Alkoholizm i Narkomania No 1(34):99-110.
37. Taracha E, Habrat B, Chmielewska K, Baran H, Szukalski B (1999b) Zastosowanie oznaczania β-heksozoaminidazy w moczu do diagnostyki nadużywania alkoholu przez osoby uzależnione od opiatów biora̧ce udział w programie substytucyjnego leczenia metadonem. Psychiat Pol 33:215-224.
38. Taracha E, Habrat B, Baran H, Chmielewska K, Walkowiak J, Szukalski B (2001) The activity of β-hexosaminidase (uHex) and γ- glutamyltransferase (uGGT) in urine as non-invasive markers of alcohol abuse. I. Alcohol-dependent subjects. World J Biol Psychiatry 2:184-189.
39. Wehr H, Habrat B, Czartoryska B, Górska D, Woronowicz B (1995) Aktywność β-heksozoaminidazy w moczu jako marker nadużywania alkoholu u osób uzależnionych. Psychiat Pol 29:689-696.
40. Wensing G, Neumann U, Ohnhaus EE, Heidemann HT (1990) Effect of antipyrine and phenobarbital on renal γ-glutamylotransferase excretion in human urine. Clin Pharmacol Ther 48:575-581.